Literature DB >> 17023389

Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis.

Mohit Kapoor1, Fumiaki Kojima, Min Qian, Lihua Yang, Leslie J Crofford.   

Abstract

Microsomal prostaglandin (PG) E synthase (mPGES)-1 is an inducible enzyme that acts downstream of cyclooxygenase (COX) and specifically catalyzes the conversion of prostaglandin (PG)H2 to PGE2, most prominently in inflammatory conditions. Specific inhibitors of mPGES-1 are not yet available, however, mice with genetic deletion of mPGES-1 have been generated that have given insight into the specific role of mPGES-1 in eicosanoid biosynthesis in vivo and in peritoneal macrophages. We created mouse embryo fibroblast (MEF) cell lines that would facilitate investigation of the effect of mPGES-1 genetic deletion on prostanoid biosynthesis in fibroblast lineage cells and its subsequent effect on the expression of inducible NOS (iNOS) and nitrite biosynthesis using cells derived from mPGES-1 wild-type (WT), heterozygous (Het), and null mice. The results show that genetic deletion of mPGES-1 results in a dramatic decrease in PGE2 production in Het and null MEFs under basal conditions and after stimulation with interleukin (IL)-1beta, suggesting that mPGES-1 is critically important for PGE2 production. Furthermore, we show that mPGES-1 gene deletion results in diversion of prostanoid production from PGE2 to 6-keto PGF1alpha (the stable metabolic product of PGI2; prostacyclin) in a gene dose-dependent manner in Het and null MEFs compared with their WT counterparts, suggesting a shunting phenomenon within the arachidonic acid (AA) metabolic pathway. In addition, we show that mPGES-1 gene deletion and subsequent decrease in PGE2 levels results in a differential induction profile of iNOS and nitrite levels (the stable breakdown product of nitric oxide (NO) in mPGES-1 WT MEFs compared with null MEFs. These results provide important information regarding the therapeutic potential for pharmacologic inhibition of mPGES-1 in inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023389      PMCID: PMC4415996          DOI: 10.1096/fj.06-6366fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  47 in total

1.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.

Authors:  S Moncada; J R Vane
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

2.  Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2.

Authors:  Yuko Kino; Fumiaki Kojima; Kazushige Kiguchi; Rie Igarashi; Bunpei Ishizuka; Shinichi Kawai
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2005-08       Impact factor: 4.006

3.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

Review 4.  Endothelial function as a determinant of vascular function and structure: a new therapeutic target.

Authors:  G H Gibbons
Journal:  Am J Cardiol       Date:  1997-03-06       Impact factor: 2.778

5.  Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages.

Authors:  Catherine E Trebino; James D Eskra; Timothy S Wachtmann; Jose R Perez; Thomas J Carty; Laurent P Audoly
Journal:  J Biol Chem       Date:  2005-02-18       Impact factor: 5.157

6.  Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages.

Authors:  L Pang; J R Hoult
Journal:  Biochem Pharmacol       Date:  1997-02-21       Impact factor: 5.858

7.  Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages.

Authors:  R Patel; M G Attur; M Dave; S B Abramson; A R Amin
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

8.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

Authors:  S G Morham; R Langenbach; C D Loftin; H F Tiano; N Vouloumanos; J C Jennette; J F Mahler; K D Kluckman; A Ledford; C A Lee; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

9.  Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.

Authors:  B F McAdam; F Catella-Lawson; I A Mardini; S Kapoor; J A Lawson; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

10.  Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium.

Authors:  M Westman; M Korotkova; E af Klint; A Stark; L P Audoly; L Klareskog; A-K Ulfgren; P-J Jakobsson
Journal:  Arthritis Rheum       Date:  2004-06
View more
  16 in total

1.  5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis.

Authors:  Victoria A Blaho; Yan Zhang; Jennifer M Hughes-Hanks; Charles R Brown
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

2.  Potential roles of microsomal prostaglandin E synthase-1 in rheumatoid arthritis.

Authors:  Fumiaki Kojima; Rahul G Matnani; Shinichi Kawai; Fumitaka Ushikubi; Leslie J Crofford
Journal:  Inflamm Regen       Date:  2011-03

3.  Reduced T cell-dependent humoral immune response in microsomal prostaglandin E synthase-1 null mice is mediated by nonhematopoietic cells.

Authors:  Fumiaki Kojima; Andrey Frolov; Rahul Matnani; Jerold G Woodward; Leslie J Crofford
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

4.  A Novel Selective Prostaglandin E2 Synthesis Inhibitor Relieves Pyrexia and Chronic Inflammation in Rats.

Authors:  Ryusuke Sugita; Harumi Kuwabara; Kotaro Sugimoto; Kazufumi Kubota; Yuichiro Imamura; Toshihiro Kiho; Atsushi Tengeiji; Katsuhiro Kawakami; Kohei Shimada
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

5.  Genetic deletion of mPGES-1 abolishes PGE2 production in murine dendritic cells and alters the cytokine profile, but does not affect maturation or migration.

Authors:  S U Monrad; F Kojima; M Kapoor; E L Kuan; S Sarkar; G J Randolph; L J Crofford
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-12-28       Impact factor: 4.006

6.  Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: a time course study.

Authors:  Mohit Kapoor; Fumiaki Kojima; Lihua Yang; Leslie J Crofford
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-01-18       Impact factor: 4.006

7.  Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.

Authors:  A Koeberle; F Pollastro; H Northoff; O Werz
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

8.  Defective generation of a humoral immune response is associated with a reduced incidence and severity of collagen-induced arthritis in microsomal prostaglandin E synthase-1 null mice.

Authors:  Fumiaki Kojima; Mohit Kapoor; Lihua Yang; Erica L Fleishaker; Martin R Ward; Seetha U Monrad; Ponnappa C Kottangada; Charles Q Pace; James A Clark; Jerold G Woodward; Leslie J Crofford
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

9.  Prostaglandin E2 activates Rap1 via EP2/EP4 receptors and cAMP-signaling in rheumatoid synovial fibroblasts: involvement of Epac1 and PKA.

Authors:  Fumiaki Kojima; Mohit Kapoor; Shinichi Kawai; Lihua Yang; David M Aronoff; Leslie J Crofford
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-25       Impact factor: 3.072

10.  Group X Secreted Phospholipase A2 Releases ω3 Polyunsaturated Fatty Acids, Suppresses Colitis, and Promotes Sperm Fertility.

Authors:  Remi Murase; Hiroyasu Sato; Kei Yamamoto; Ayako Ushida; Yasumasa Nishito; Kazutaka Ikeda; Tetsuyuki Kobayashi; Toshinori Yamamoto; Yoshitaka Taketomi; Makoto Murakami
Journal:  J Biol Chem       Date:  2016-01-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.